Levetiracetamum [INN-Latin] en es it fr

Levetiracetamum [INN-Latin] Brand names, Levetiracetamum [INN-Latin] Analogs

Levetiracetamum [INN-Latin] Brand Names Mixture

  • No information avaliable

Levetiracetamum [INN-Latin] Chemical_Formula

C15H12I3NO4

Levetiracetamum [INN-Latin] RX_link

http://www.rxlist.com/cgi/generic3/liothyronine.htm

Levetiracetamum [INN-Latin] fda sheet

Levetiracetamum_[INN-Latin] FDA

Levetiracetamum [INN-Latin] msds (material safety sheet)

Levetiracetamum_[INN-Latin] MSDS

Levetiracetamum [INN-Latin] Synthesis Reference

No information avaliable

Levetiracetamum [INN-Latin] Molecular Weight

650.974 g/mol

Levetiracetamum [INN-Latin] Melting Point

236.5 oC

Levetiracetamum [INN-Latin] H2O Solubility

3.96 mg/L

Levetiracetamum [INN-Latin] State

Solid

Levetiracetamum [INN-Latin] LogP

3.001

Levetiracetamum [INN-Latin] Dosage Forms

Tablet

Levetiracetamum [INN-Latin] Indication

Used as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyrodism during the recovery phase of subacute thyroiditis.

Levetiracetamum [INN-Latin] Pharmacology

Thyroid hormone drugs are natural or synthetic preparations containing tetraiodothyronine (T4, levothyroxine) or triiodothyronine (T3, liothyronine) or both. T4 and T3 are produced in the human thyroid gland by the iodination and coupling of the amino acid tyrosine. Liothyronine (T3) contains three atoms of iodine and is formed by the coupling of one molecule of diiodotyrosine (DIT) with one molecule of monoiodotyrosine (MIT). These hormones enhance oxygen consumption by most tissues of the body and increase the basal metabolic rate and the metabolism of carbohydrates, lipids and proteins. Thus, they exert a profound influence on every organ system in the body and are of particular importance in the development of the central nervous system.

Levetiracetamum [INN-Latin] Absorption

Almost totally absorbed, 95 percent in 4 hours.

Levetiracetamum [INN-Latin] side effects and Toxicity

No information avaliable

Levetiracetamum [INN-Latin] Patient Information

Levetiracetamum [INN-Latin] Organisms Affected

Humans and other mammals